HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.

AbstractBACKGROUND:
Abelson (Abl) interactor 2 (Abi-2) has been considered as a key regulator of cell/tissue structural organization and is differentially expressed in leiomyomas. The objective of this study was to evaluate the expression of Abi-2 in leiomyoma/myometrium during the menstrual cycle and following GnRH analogue (GnRHa) therapy, as well as regulation by transforming growth factor (TGF)-beta1 in leiomyoma and myometrial smooth muscle cells (LSMC and MSMC).
METHODS:
We used real-time PCR, Western blotting and immunohistochemistry to determine the expression of Abi-2 in paired leiomyoma and myometrium (n = 27) from proliferative (n = 8) and secretory (n = 12) phases of the menstrual cycle and from patients who received GnRHa therapy (n = 7). Time-dependent action of TGF-beta1 (2.5 ng/ml) and GnRHa (0.1 microM) on Abi-2 expression was determined in LSMC and MSMC.
RESULTS:
Leiomyomas express elevated levels of Abi-2 as compared with myometrium from the proliferative but not the secretory phase of the menstrual cycle, with a significant reduction following GnRHa therapy (P < 0.05). Western blotting showed a similar trend in Abi-2 protein expression in leiomyoma/myometrial tissue extracts, which was immunolocalized in LSMC and MSMC, connective tissue fibroblasts and arterial walls. The expression of Abi-2 in LSMC and MSMC was increased by TGF-beta1 (2.5 ng/ml) and was inhibited by GnRHa (0.1 microM) in a time- and cell-dependent manner, and pretreatment with Smad3 SiRNA and U0126, an MEK-1/2 inhibitor, respectively, reversed their actions.
CONCLUSION:
Based on the menstrual cycle-dependent expression, the influence of GnRHa therapy, and regulation by TGF-beta in LSMC/MSMC, we conclude that Abi-2 may have a key regulatory function in leiomyomas cellular/tissue structural organization during growth and regression.
AuthorsXiaoping Luo, Eric Levens, R Stan Williams, Nasser Chegini
JournalHuman reproduction (Oxford, England) (Hum Reprod) Vol. 21 Issue 6 Pg. 1380-6 (Jun 2006) ISSN: 0268-1161 [Print] England
PMID16488906 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • ABI2 protein, human
  • Adaptor Proteins, Signal Transducing
  • Transforming Growth Factor beta
  • Gonadotropin-Releasing Hormone
Topics
  • Adaptor Proteins, Signal Transducing (biosynthesis)
  • Adult
  • Cell Proliferation
  • Female
  • Gene Expression Regulation, Neoplastic
  • Gonadotropin-Releasing Hormone (analogs & derivatives)
  • Humans
  • Leiomyoma (metabolism)
  • MAP Kinase Signaling System
  • Menstrual Cycle
  • Myocytes, Smooth Muscle (metabolism)
  • Myometrium (metabolism, pathology)
  • Transforming Growth Factor beta (metabolism)
  • Uterine Neoplasms (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: